Feature
Hepatitis outbreak in children: What do we know so far?
Scientists and healthcare professionals around the world are continuing to investigate a sudden increase in hepatitis cases in children.
1
Kisspeptin reduces liver damage in non-alcoholic fatty liver disease in mice
New research finds that a hormone previously linked to attraction may have the potential to treat liver disease.
Cyclones health impact and squeezing cells: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
Imperial launches its first public health online degree
The Global Master of Public Health, developed alongside Coursera, is Imperial's first fully-online degree in the health field.
Feature
How can we accelerate the elimination of viral hepatitis?
A global panel of experts have published their key recommendations to advance the fight against viral hepatitis.
Video
A new wave of technology is set to transform surgery for millions of patients
An independent commission has predicted that surgery is about to be transformed for millions of patients by a new wave of technologies.
Liver cancer cell ‘switch’ found that could improve future therapies
Imperial researchers have found a new cell mechanism that could be used to target tumours in the future.
Gut bacteria markers could be a ‘smoking gun’ for liver disease
Chemical compounds produced by the bacteria in our gut could be used to spot the early stages of liver disease, according to new research.
Early death and ill health linked to low socioeconomic status
Scientists found that poverty and poor education are linked to ill health and early death, and should be considered risk factors for these outcomes.
Video
SCI, part of the 20th anniversary celebrations of Queen's Anniversary Prizes
SCI chosen as the subject of a celebratory film made for the Queen, highlighting the achievements of SCI before and after receiving the award.
